Get started
Author

Florian Abel

Observed names: Abel, Florian, F Abel, F. Abel
OpenAlex ID: A5109055541
Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
2021 · Suresh Vijay, Anais Brassier, et al. · Orphanet Journal of Rare Diseases · 39
Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
2020 · Vĕra Malinová, Manisha Balwani, et al. · Liver International · 24
Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry
2023 · Manisha Balwani, William Balistreri, et al. · Liver International · 22
PDF
Long‐Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency
2022 · Barbara K. Burton, Alejandra Consuelo Sanchez, et al. · Journal of Pediatric Gastroenterology and Nutrition · 22
Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies
2021 · Suresh Vijay, Anais Brassier, et al. · Orphanet Journal of Rare Diseases · 13
PDF
Early diagnosis and successful long-term management of a rare, severe lysosomal acid lipase deficiency/Wolman disease patient: Infancy to age five
2022 · Antoine Cossette, Julie Castilloux, et al. · Canadian Liver Journal · 3
PDF
Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry
2025 · Lorenzo D'Antiga, Jennifer Evans, et al. · Liver International · 2
Best Practices for the Nutritional Management of Infantile-Onset Lysosomal Acid Lipase Deficiency: A Case-Based Discussion
2026 · Fiona J. White, Javier de las Heras, et al. · Nutrients · 1
PDF
Survival, growth, and safety findings in patients with rapidly progressive, infantile-onset LAL-D: Results from the international LAL-D registry
2025 · Suresh Vijay, Jennifer Evans, et al. · Molecular Genetics and Metabolism · 1
Survival achieved in infants with rapidly progressive LAL-D via sebelipase alfa ERT: Results from the International LAL-D Registry
2025 · Suresh Vijay, Jennifer Evans, et al. · Molecular Genetics and Metabolism · 1
OS-082 Sustained improvement of alanine aminotransferase levels in patients with lysosomal acid lipase deficiency treated with sebelipase alfa enzyme replacement therapy: longitudinal data from the international lysosomal acid lipase deficiency registry
2024 · William Balistreri, Jennifer Evans, et al. · Journal of Hepatology · 1
PS-196-Efficacy and safety of sebelipase alfa over 144 weeks in a diverse population of children and adults with lysosomal acid lipase deficiency
2019 · Barbara Burton, Alejandra Consuelo Sanchez, et al. · Journal of Hepatology · 1
Benefit of Sebelipase Alfa in Children and Adults with Lysosomal Acid Lipase Deficiency Based on Analysis of Efficacy by Baseline Alanine Aminotransferase Level
2016 · F. Abel, J.-B. Arnoux, et al. · Journal of Hepatology · 1
Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry
2026 · Don P. Wilson, Lorenzo D'Antiga, et al. · Atherosclerosis
Sebelipase Alfa-naive Patients With Lal-d Are More Likely to Be Treated With Lipid-modifying Medications Than Sebelipase Alfa-treated Patients: an Analysis From the International Lal-d Registry
2026 · Don Wilson, Ursula Kassner, et al. · Atherosclerosis
OS-058 Assessment of liver injury and genotype among children and adults with lysosomal acid lipase deficiency: analysis of the international LAL D registry
2026 · William Balistreri, Ali Canbay, et al. · Journal of Hepatology
Real-World Study of Management and Outcomes of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) in France
2026 · Florence Lacaille, Sophie Marguet, et al. · Advances in Therapy
PDF
Outcomes of patients with rapidly progressive lysosomal acid lipase deficiency treated with sebelipase alfa before hematopoietic stem cell transplantation
2026 · Barbara MacFee, Suresh Vijay, et al. · Molecular Genetics and Metabolism
Sebelipase alfa treatment results in sustained improvement of lipid parameters in symptomatic pediatric and adult LAL-D patients: Longitudinal data from the international LAL-D registry
2025 · Don Wilson, Jennifer Evans, et al. · Atherosclerosis
THU-319 Sebepliase alfa improves lipid metabolism and liver outcomes in pediatric patients with lysosomal acid lipase deficiency
2025 · William Balistreri, Lorenzo D’Antiga, et al. · Journal of Hepatology
† Sebelipase alfa results in sustained improvement of lipid parameters in symptomatic LAL-D: Longitudinal data from the International LAL-D Registry
2025 · Don Wilson, Jennifer Evans, et al. · Journal of clinical lipidology
Survival achieved in infants with rapidly progressive LAL-D via sebelipase alfa ERT: Results from the International LAL-D Registry
2024 · Suresh Vijay, Florence Lacaille, et al. · Molecular Genetics and Metabolism
A216 Clinical Manifestations of Lysosomal Acid Lipase Deficiency (lal-d): the International Lal-d Registry
2021 · M Francis, M Balwani, et al. · Journal of the Canadian Association of Gastroenterology
Clinical manifestations of lysosomal acid lipase deficiency (LAL-D): The international LAL-D registry
2020 · Manisha Balwani, William Balistreri, et al. · Molecular Genetics and Metabolism
Clinical manifestations of LAL-D: The international lysosomal acid lipase deficiency registry
2019 · Manisha Balwani, William Balistreri, et al. · Molecular Genetics and Metabolism
Works count: 30
Citation count: 131
H-index: 5
I10-index: 5
Year
Topic
Type